United States · FDA National Drug Code directory
Replenix Gly-Sal 2-2
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51326-925_d8528811-6b8f-4332-96c2-753657502234
- Product NDC
- 51326-925
- Form
- LIQUID
- Composition / generic term
- salicylic acid
- Labeler
- Topiderm, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20190723
- Source listing expiry
- 20261231
Source-listed ingredients
- SALICYLIC ACID — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 200 mL in 1 BOTTLE (51326-925-01) · 51326-925-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →